Craig C. Hofmeister, MD, MPH
Craig C. Hofmeister is Associate Professor, Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in internal medicine and hematology, Dr. Hofmeister’s practice focuses on plasma cell cancers including plasmacytomas, multiple myeloma, AL amyloidosis, smoldering myeloma, and monoclonal gammopathies of renal significance. He started practicing with Emory Healthcare in 2018.
Dr. Hofmeister earned his medical degree (MD) and his Master of Public Health (MPH) degree in clinical investigation from The Ohio State University in Columbus, Ohio. He completed his internship and hematology fellowship at Loyola University.
Dr. Hofmeister’s research focuses on early drug development and investigator-initiated clinical trials exploring novel diagnostics and treatments. As a translational researcher, he has been funded continuously from the National Cancer Institute (NCI) since 2016.
Representative Publications:
BEAM or BUCYVP16-Conditioning Regimen for Autologous Stem-Cell Transplantation in Non-Hodgkin’s Lymphomas
Survival Outcomes of Patients With Primary Plasma Cell Leukemia (Ppcl) Treated With Novel Agents
Population Pharmacokinetics of Lenalidomide in Patients With B-Cell Malignancies
A Single Nucleotide Polymorphism in SLC7A5 was Associated With Clinical Response in Multiple Myeloma Patients
Psychosocial Risk Predicts High Readmission Rates for Hematopoietic Cell Transplant Recipients
